TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis

Oncogene

Volumn 34, Issue 4, 2015, Pages 436-444

  Cyr, A R ^a   Kulak, M V ^a   Park, J M ^a   Bogachek, M V ^a   Spanheimer, P M ^a   Woodfield, G W ^a   White Baer, L S ^a   O'Malley, Y Q ^a   Sugg, S L ^a   Olivier, A K ^a   Zhang, W ^a   Domann, F E ^a   Weigel, R J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

breast cancer; EMT; gene expression; luminal; mammary development; TFAP2C

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; TFAP2C PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 2;

ANIMAL; BREAST; BREAST NEOPLASMS; CANCER STEM CELL; CARCINOGENESIS; CHEMISTRY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KNOCKOUT MOUSE; MOUSE; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; BREAST; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASTIC STEM CELLS; PHENOTYPE; TRANSCRIPTION FACTOR AP-2;

EID: 85028265467     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.569     Document Type: Article

References (37)

1. Friedrichs N, Steiner S, Buettner R, Knoepfle G. Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast. Histopathology 2007; 51: 814-823.
2. Gee JM, Eloranta JJ, Ibbitt JC, Robertson JF, Ellis IO, Williams T et al. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J Pathol 2009; 217: 32-41.
3. Friedrichs N, Jager R, Paggen E, Rudlowski C, Merkelbach-Bruse S, Schorle H et al. Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer. Mod Pathol 2005; 18: 431-438.
4. McPherson LA, Baichwal VR, Weigel RJ. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci USA 1997; 94: 4342-4347.
5. Woodfield GW, Horan AD, Chen Y, Weigel RJ. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res 2007; 67: 8439-8443.
6. Ailan H, Xiangwen X, Daolong R, Lu G, Xiaofeng D, Xi Q et al. Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells. BMC Cancer 2009; 9: 279.
7. Delacroix L, Begon D, Chatel G, Jackers P, Winkler R. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells. DNA Cell Biol 2005; 24: 582-594.
8. Bosher JM, Williams T, Hurst HC. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 1995; 92: 744-747.
9. Woodfield GW, Chen Y, Bair TB, Domann FE, Weigel RJ. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chromosomes Cancer 2010; 49: 948-962.
10. Tan SK, Lin ZH, Chang CW, Varang V, Chng KR, Pan YF et al. AP-2gamma regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J 2011; 30: 2569-2581.
11. Qiao Y, Zhu Y, Sheng N, Chen J, Tao R, Zhu Q et al. AP2gamma regulates neural and epidermal development downstream of the BMP pathway at early stages of ectodermal patterning. Cell Res 2012; 22: 1546-1561.
12. Hoffman TL, Javier AL, Campeau SA, Knight RD, Schilling TF. Tfap2 transcription factors in zebrafish neural crest development and ectodermal evolution. J Exp Zool B Mol Dev Evol 2007; 308: 679-691.
13. Jager R, Friedrichs N, Heim I, Buttner R, Schorle H. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis. Breast Cancer Res Treat 2005; 90: 273-280.
14. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, Williams T. Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. Development 2002; 129: 2733-2747.
15. Jager R, Schafer S, Hau-Liersch M, Schorle H. Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland. Dev Dyn 2010; 239: 1027-1033.
16. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009; 4: e6146.
17. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989-997.
18. Groger CJ, Grubinger M, Waldhor T, Vierlinger K, Mikulits W. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS One 2012; 7: e51136.
19. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
20. Guttormsen J, Koster MI, Stevens JR, Roop DR, Williams T, Winger QA. Disruption of epidermal specific gene expression and delayed skin development in AP-2 gamma mutant mice. Dev Biol 2008; 317: 187-195.
21. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997; 25: 4323-4330.
22. Kalyuga M, Gallego-Ortega D, Lee HJ, Roden DL, Cowley MJ, Caldon CE et al. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer. PLoS Biol 2012; 10: e1001461.
23. Buchwalter G, Hickey MM, Cromer A, Selfors LM, Gunawardane RN, Frishman J et al. PDEF promotes luminal differentiation and acts as a survival factor for ERpositive breast cancer cells. Cancer Cell 2013; 23: 753-767.
24. Bai F, Smith MD, Chan HL, Pei XH. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene 2013; 32: 2715-2725.
25. Balko JM, Miller TW, Morrison MM, Hutchinson K, Young C, Rinehart C et al. The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium. Proc Natl Acad Sci USA 2012; 109: 221-226.
26. Bernardo GM, Bebek G, Ginther CL, Sizemore ST, Lozada KL, Miedler JD et al. FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene 2013; 32: 554-563.
27. Carr JR, Kiefer MM, Park HJ, Li J, Wang Z, Fontanarosa J et al. FoxM1 regulates mammary luminal cell fate. Cell Rep 2012; 1: 715-729.
28. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
29. dos Santos CO, Rebbeck C, Rozhkova E, Valentine A, Samuels A, Kadiri LR et al. Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells. Proc Natl Acad Sci USA 2013; 110: 7123-7130.
30. Spanheimer PM, Askeland RW, Kulak MV, Wu T, Weigel RJ. High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer. J Surg Res 2013; 184: 519-525.
31. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K. Heterogeneity for stem cellrelated markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 2010; 16: 876-887.
32. Ricardo S, Vieira AF, Gerhard R, Leitao D, Pinto R, Cameselle-Teijeiro JF et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 2011; 64: 937-946.
33. Lee HE, Kim JH, Kim YJ, Choi SY, Kim SW, Kang E et al. An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Br J Cancer 2011; 104: 1730-1738.
34. deConinck EC, McPherson LA, Weigel RJ. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol Cell Biol 1995; 15: 2191-2196.
35. Plante I, Stewart MK, Laird DW. Evaluation of mammary gland development and function in mouse models. J Vis Exp (e-pub ahead of print 21 July 2011; pii:2828, doi:10.3791/2828).
36. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-997.
37. Smalley MJ. Isolation, culture and analysis of mouse mammary epithelial cells. Methods Mol Biol 2010; 633: 139-170.